Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04036396 · ClinicalTrials.gov registry record · NA
Mobile Enhanced Prevention Support for People Leaving Jail
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 233
- Enrollment target
NCT04036396: Completed NA study, sponsored by University of California, Los Angeles.
NCT04036396 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 233 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04036396, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 233 participants
- Enrollment target
Study Summary
This study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and other support services between individuals who receive routine case management provided following enrollment to those who have access to GeoPassport, a global position service (GPS)-based mobile app, incentives, and peer mentor support.
Primary Outcome
Defined as the participant identifying and completing an appointment with a primary care provider who is willing and able to prescribe HIV pre-exposure prophylaxis.
Interventions
- BEHAVIORAL Mobile Enhanced Prevention Support
- BEHAVIORAL Usual Care plus Customized Referrals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2019-11-14 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
What the finished NCT04036396 record still lists
NCT04036396 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Mobile Enhanced Prevention Support is the first listed.
NCT04036396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04036396 about?
NCT04036396 is a clinical study titled "Mobile Enhanced Prevention Support for People Leaving Jail". This study will provide HIV prevention and related support services to men who have sex with men and transgender women who have substance use disorders and are either leaving jail or recently released from jail. The researchers will compare the utilization of HIV prevention and other support service...
What is the current status of trial NCT04036396?
This trial is currently completed. It is a NA study. The enrollment target is 233 participants. The study started on 2019-11-14. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04036396?
The interventions under investigation include: Mobile Enhanced Prevention Support (BEHAVIORAL), Usual Care plus Customized Referrals (BEHAVIORAL).
Who is sponsoring clinical trial NCT04036396?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04036396's enrollment target sits among peer trials
233 463rd of 2000 higher than 1,538 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI